TOCQUEVILLE ASSET MANAGEMENT L.P. - LA JOLLA PHARMACEUTICAL CO ownership

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2018$252,000
+7.7%
8,650
+10.2%
0.00%0.0%
Q1 2018$234,000
-88.8%
7,850
-88.8%
0.00%
-88.0%
Q2 2017$2,088,000
-0.1%
70,150
+0.1%
0.02%
-3.8%
Q1 2017$2,091,000
+138.4%
70,050
+40.1%
0.03%
+136.4%
Q4 2016$877,000
-2.8%
50,000
+31.9%
0.01%0.0%
Q3 2016$902,000
-22.5%
37,900
-47.9%
0.01%
+57.1%
Q2 2016$1,164,000
+53.0%
72,800
+100.0%
0.01%
-30.0%
Q1 2016$761,000
-7.3%
36,400
+19.7%
0.01%
-9.1%
Q4 2015$821,000
+294.7%
30,400
+305.3%
0.01%
+266.7%
Q3 2015$208,000
-19.7%
7,500
-73.4%
0.00%0.0%
Q2 2014$259,000
-10.4%
28,225
+5.6%
0.00%
-25.0%
Q1 2014$289,00026,7250.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders